Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ADHD Individual Drug Risk Studies To Be Considered By Drug Safety Committee

Feb 08 2006

• By Mary Bruce

Related Content

Cardiac, Neuropsychiatric Events With ADHD Drugs To Be Discussed By Pediatric Committee

Jan 25 2006

Shire Adderall XR Sales Suspended In Canada; FDA Stands By "Black Box"

Feb 10 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window